Boston, MA -- (SBWIRE) -- 09/13/2012 -- EKF Diagnostics Holdings plc (EKF Diagnostics), formerly International Brand Licensing plc, is a medical device company. It undertakes the design, development, manufacture and marketing of point of care blood analyzing equipments and reagents for the detection and management of anemia, diabetes, lactate, and renal diseases among others. The company's product portfolio includes hemoglobin analyzers glycated hemoglobin analyzers, glucose analyzers, lactate analyzers, liquid stable reagents and pregnancy test strips. EKF Diagnostics markets these products to GP surgeries, pharmacies, blood banks, sports clinics, hospitals, and laboratories through a network of distributors in over 70 countries. The company has its research and manufacturing facilities spread across Germany, Ireland, the US and the UK. EKF Diagnostics is headquartered in London, England, the UK.
The company focuses on rapid and cost-effective delivery of quality products to a diverse group of customers. EKF Diagnostics seeks to build a leading position in the marketplace through internal development, new product launches, research and development, strong partner relationships, strategic alliances and acquisitions. As a part of its strategy, the company acquired Quotient Diagnostics, Argutus Medical and Stanbio Laboratory.
View Full Report Details and Table of Contents
This report is a source for data, analysis and actionable intelligence on the EKF Diagnostics Holdings plc portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
Browse all Medical Devices research reports at Fast Market Research
You may also be interested in these related reports:
- Trinity Biotech Plc (TRIB) - Product Pipeline Analysis
- Siemens Healthcare Diagnostics, Inc. - Product Pipeline Analysis
- Abbott Diagnostics - Product Pipeline Analysis
- Chembio Diagnostics, Inc. (CEMID) - Product Pipeline Analysis
- Ortho-Clinical Diagnostics Inc. - Product Pipeline Analysis
- Alphatec Holdings, Inc. (ATEC) - Product Pipeline Analysis
- EXINI Diagnostics AB (EXINI) - Product Pipeline Analysis
- Product Pipeline in Medical Equipment Market - Robust Pipeline Strengthening the In-Vitro Diagnostics and Cardiovascular Devices Market
- GenMark Diagnostics, Inc. (GNMK) - Product Pipeline Analysis
- In Vitro Diagnostics Market to 2018 - Consolidation, Decentralization and Demand for Genetic Testing to Shape the Competitive Landscape